Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (8)

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

2020

  1. Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro

    Computational and Structural Biotechnology Journal, Vol. 18, pp. 953-966

  2. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease

    European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596

2019

  1. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease

    Nefrologia, Vol. 39, Núm. 3, pp. 287-293

2017

  1. Markers of endothelial damage in patients with chronic kidney disease on hemodialysis

    American Journal of Physiology - Renal Physiology, Vol. 312, Núm. 4, pp. F673-F681

  2. Residual Renal Function in Hemodialysis and Inflammation

    Therapeutic Apheresis and Dialysis, Vol. 21, Núm. 6, pp. 592-598

2016

  1. Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab

    Biochemical Pharmacology, Vol. 122, pp. 33-41